Search Results 361-370 of 19032 for alzheimers
These Alzheimer's disease medicines increase levels of chemical messengers in the brain, known as neurotransmitters. These chemical messengers are believed to ...
– After legendary basketball coach Pat Summitt was diagnosed with early-onset Alzheimer's disease at Mayo Clinic in 2011, the winningest coach in NCAA Division ...
Learn about publications and news in Nilufer Ertekin-Taner's Genetics of Alzheimer's Disease and Endophenotypes lab at Mayo Clinic.
A multidisciplinary faculty guides research in the Mayo Clinic Alzheimer's Disease Research Center.
Alzheimer's Disease Research Center. Director's Message. Dear Mayo Clinic Study of Aging participants,. Thanks to each of you, we have been able to make ...
"Alzheimer's disease research is at a low point right now with regard to therapeutics. We've had many drug failures. Recently, a whole class of drugs has shown ...
The purpose of this study is the validation of biomarker measures and to nform clinical trial design. Participation eligibility. Participant eligibility ...
Taner, is analyzing brain tissue and blood samples from living patients with Alzheimer's disease and varying levels of cerebrovascular pathology. The ...
Targeting Neuroinflammation as a Contributing Pathology in Alzheimer's Disease Dementia · More about research at Mayo Clinic · Mayo Clinic Footer.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift today can have 5X the impact on AI research and technology. But hurry — the match challenge ends 9/19.